Skip to main content
OpenTrials

Clinical trial condition

Leiomyosarcoma

Explore clinical trials studying Leiomyosarcoma. Study availability and eligibility vary by location and protocol.

116 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Leiomyosarcoma trial results

Recruiting

AOH1996 for the Treatment of Refractory Solid Tumors

NCT05227326

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +39 more
Locations
  • Honor Health Research and Innovation Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
View Trial Details
Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293

Conditions
Dedifferentiated Liposarcoma, Leiomyosarcoma, Liposarcoma, +7 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health Cancer Institute Lake Success, New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

NCT05711615

Conditions
Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +24 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Recruiting

Localized Leiomyosarcoma Biomarker Protocol

NCT04925089

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Recruiting

Metastatic Leiomyosarcoma Biomarker Protocol

NCT05653388

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • University of Miami Miami, Florida, United States
  • Dana- Farber Boston, Massachusetts, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT06789172

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
View Trial Details
Recruiting

A Study of Ivonescimab in People With Leiomyosarcoma

NCT07516925

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions